Clinical TrialID 5655

Clozapine-induced Hypersalivation - Feasibility Trial

NCT02613494

Sialorrhea

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
5655
Evidence Id
5655
Core Evidence Id
5655
Source Clinical Trial Id
5641
Herb2 Clinical Trial Id
HBCT005641
Nct Id
NCT02613494
Title
Clozapine-induced Hypersalivation - Feasibility Trial
Status
Completed
Phase
Phase 1|Phase 2
Study Result
No
Study Condition
Sialorrhea
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Hyoscine|DRUG: Glycopyrrolate|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
29
Outcome Measure
Number of participants recruited and number of participants finishing the study, Assessed at the end of the study (20 months after start of study)
Sponsor Collaborator
Mersey Care NHS Trust|University of Manchester|University of Central Lancashire|Manchester Mental Health & Social Care Trust|Lancashire Care NHS Foundation Trust
Funded By
OTHER
Location
Lancashire Care NHS Foundation Trust, Preston, Lancashire, United Kingdom|Mersey Care NHS Trust, Liverpool, Merseyside, United Kingdom
Other Id
2015-GOTHIC1
Start Date
2016-01-25
Primary Completion Date
2017-12-31
Completion Date
2018-02-23
First Posted
2015-11-24
Results First Posted
Last Update Posted
2018-02-28
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02613494
Title Cn
Title En
Clozapine-induced Hypersalivation - Feasibility Trial
Bilingual Status
semi_complete